β-lactamase producing enterobacteria isolated from surveillance swabs of patients in a Cardiac Intensive Care Unit in Rio de Janeiro, Brazil

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 1, 2011, Pages 28-33

  Vasques, Marcia Regina G ^a   Bello, Alexandre Ribeiro ^b   Lamas, Cristiane da Cruz ^a   Correa, Juarez ^c   Pereira, José Augusto Adler ^b  

^a INSTITUTO NACIONAL DE CARDIOLOGIA   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Laboratório LABOSERV   (Brazil)

Author keywords

Enterobacteriaceae infections; Infection control; Polymerase chain reaction

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M1; BETA LACTAMASE SHV; BETA LACTAMASE TEM; BETA LACTAMASE TOHO 1; CEFTRIAXONE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; BRAZIL; CONTROLLED STUDY; DISEASE SURVEILLANCE; ENZYME SYNTHESIS; ESCHERICHIA COLI; FECES ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEUS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CROSS INFECTION; ENTEROBACTERIACEAE; GENOTYPE; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; POLYMERASE CHAIN REACTION; RECTUM;

EID: 79955974792     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702011000100006     Document Type: Article

References (26)

1. Murray P.R., Rosenthal K.S., Pfaller M.A. Microbiologia Médica 2006, 7. Elsevier, 187-315.
2. Souza M.A. β-lactamase de Espectro Ampliado (ESBL): um importante mecanismo de resistência Bacteriana e sua detecção no Laboratório Clínico. Newslab 2004, 63:152-174.
3. Jacoby G.A. AmpC beta-lactamases. Clin Microbiol Rev 2009, 22(1):161-182. Jan.
4. Rossi F., Andreazzi D.B. Resistência Bacteriana, interpretando o antibiograma 2005, São Paulo, Editora Atheneu.
5. Jacoby G.A., Munoz-Price L.S. The new beta-lactamases. N Engl J Med 2005 Jan 27, 352(4):380-391.
6. Queenan A.M., Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007, 20(3):440-458. Jul.
7. Samra Z., Ofir O., Lishtzinsky Y., Madar-Shapiro L., Bishara J. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 2007, 30(6):525-529. Dec.
8. Peirano G., Seki L.M., Val Passos V.L., Pinto M.C., Guerra L.R., Asensi M.D. Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil. J Antimicrob Chemother 2009, 63(2):265-268. Feb; Epub 2008 Nov 20.
9. Villegas M.V., Lolans K., Correa A., et al. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 2006, 50(8):2880-2882. Aug.
10. MMWR. Guidance for Control of infection with carbapenemresistant or carbapenemase-producing Enterobacteriaceae in Acute care Facilities, 2009, 58: 256-260.
11. Bratu S., Landman D., Alam M., Tolentino E., Quale J. Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob Agents Chemother 2005, 49(2):776-778. Feb.
12. Clinical and Laboratory Standards Institute Performance. Standards for antimicrobial Susceptibility Testing, 2009.
13. Silva J., Gatica R., Aguilar C., et al. Outbreak of infection with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Mexican hospital. J Clin Microbiol 2001, 39(9):3193-3196. Sep.
14. Pitout J.D., Hossain A., Hanson N.D. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol 2004, 42(12):5715-5721. Dec.
15. Conceição T., Faria N., Lito L., Melo Cristino J., Salgado M.J., Duarte A. Diversity of chromosomal AmpC beta-lactamases from Enterobacter cloacae isolates in a Portuguese hospital. FEMS Microbiol Lett 2004, 230(2):197-202. Jan 30.
16. Pitout J.D., Nordmann P., Laupland K.B., Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005, 56(1):52-59. Jul; Epub 2005 May 25.
17. Martins I.S., Pessoa-Silva C.L., Nouer S.A., et al. Endemic extended-spectrum beta-lactamase-producing Klebsiella pneumoniae at an intensive care unit: risk factors for colonization and infection. Microb Drug Resist 2006, 12(1):50-58. Spring.
18. Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8(3):159-166. Mar.
19. Kollef M.H., Wards S. The influence of mini BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998, 113:412-420.
20. Clinical and Laboratory Standards Institute Performance. Standards for antimicrobial Susceptibility Testing, 2008.
21. Clinical and Laboratory Standards Institute Performance. Standards for antimicrobial Susceptibility Testing, 2010.
22. Bertrand X., Hocquet D., Boisson K., Siebor E., Plésiat P., Talon D. Molecular epidemiology of Enterobacteriaceae producing extended-spectrum beta-lactamase in a French university-affiliated hospital. Int J Antimicrob Agents 2003, 22(2):128-133. Aug.
23. Overturf G.D. Carbapenemase: a brief review for pediatric infectious disease specialists. Pediatr Infect Dis J. 2010, 29:68-70.
24. Munoz-Price L.S., Hayden M.K., Lolans K. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. Pneumoniae at a long-term acute care hospital. Infection Control and Hospital Epidemiology 2010, 31(4):341-347.
25. Livermore DM, Paterson DL. Pocket Guide to Extended-Spectrum β-Lactamase in Resistance, 2005. Published by Current Medicine Group LTDA.
26. Paterson DL, Bonomo RA. Extended-Spectrum β-Lactamase: a clinical update. Clinical Microbiology Reviews, 2005, pp. 657-686.